Oaktree Acquisition Corp III Life Sciences Warrant
OACCW
26 hedge funds and large institutions have $2.07M invested in Oaktree Acquisition Corp III Life Sciences Warrant in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
1% less capital invested
Capital invested by funds: $2.09M → $2.07M (-$22K)
1.58% less ownership
Funds ownership: 74.97% → 73.39% (-1.6%)
10% less funds holding
Funds holding: 29 → 26 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$97.1K |
| 2 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$62.5K |
| 3 |
DAM
Decagon Asset Management
London,
United Kingdom
|
+$11.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$128K |
| 2 |
DAM
DLD Asset Management
New York
|
-$31.6K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$28.2K |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$6.28K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.65K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
26
Clear Street
New York
| $6.66K | – | – | – |
|
27
UBS Group
Zurich,
Switzerland
| $138 | – | – | – |
|
|
DCM
28
Driehaus Capital Management
Chicago,
Illinois
| – | -$128K | -180,000 | Closed |
|
|
DAM
29
DLD Asset Management
New York
| – | -$31.6K | -44,519 | Closed |
|
|
30
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$28.2K | -39,680 | Closed |
|
OACCW Hedge Fund Activity: Q1 2026 in Review
26 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) for Q1 2026, worth a combined $2.07M — down 1.1% from $2.09M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of OACCW and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Toronto Dominion Bank, adding an estimated $97.1K. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $128K sold.
- 26 institutional investors held Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) as of Q1 2026, down from 29 in Q4 2025.
- Funds reported $2.07M of Oaktree Acquisition Corp III Life Sciences Warrant stock for Q1 2026, down 1.1% quarter-over-quarter.
- 0 funds opened new Oaktree Acquisition Corp III Life Sciences Warrant positions in Q1 2026 and 3 closed out, a net change of -3 holders.
- The largest Oaktree Acquisition Corp III Life Sciences Warrant buyer in Q1 2026 was Toronto Dominion Bank, an estimated $97.1K added.
- The largest Oaktree Acquisition Corp III Life Sciences Warrant seller in Q1 2026 was Driehaus Capital Management, an estimated $128K sold.
Based on aggregated 13F filings for Q1 2026.